Uncategorized
Sustained low-dose steroid slows progression of diabetic retinopathy
SAN FRANCISCO — A sustained low-dose intravitreal steroid delayed progression of proliferative diabetic retinopathy, according to a study presented at the American Society of Retina Specialists annual meeting here. Raymond Iezzi, MD , presented data culled from the FAME trials.